2018 annual financial data
ADMA Biologics 2018 Operating margin
Direct answer
Operating margin was -354.95%.
Operating income was -60,288,944 USD and net income was -65,743,445 USD.
Operating cash flow was -62,678,682 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,985,290 USD
- Operating income
- -60,288,944 USD
- Net income
- -65,743,445 USD
- Operating cash flow
- -62,678,682 USD